Table 6.
Results of multiple linear regression analysis between change in hemoglobin A1c and baseline clinical and biochemical characteristics and parameters
| Model 1 | β | SE | 95% CI | P value |
|---|---|---|---|---|
| FPG (mg/dL) | 0.008 | 0.002 | 0.004 to 0.013 | 0.001 |
| Male sex | 0.143 | 0.174 | −0.211 to 0.496 | 0.418 |
| Age (years) | 0.007 | 0.001 | −0.013 to 0.027 | 0.490 |
| Duration of diabetes (years) | −0.008 | 0.010 | −0.029 to 0.013 | 0.442 |
| BMI (kg/m2) | −0.030 | 0.019 | −0.068 to 0.008 | 0.122 |
| LDL-C (mg/dL) | −0.005 | 0.005 | −0.015 to 0.006 | 0.370 |
| Model 2 | β | SE | 95% CI | P value |
|---|---|---|---|---|
| CPR index | −0.308 | 0.133 | −0.577 to −0.038 | 0.026 |
| Male sex | 0.078 | 0.187 | −0.025 to 0.020 | 0.679 |
| Age (years) | −0.002 | 0.011 | −0.025 to 0.020 | 0.829 |
| Duration of diabetes (years) | −0.013 | 0.012 | −0.036 to 0.011 | 0.286 |
| BMI (kg/m2) | −0.005 | 0.020 | −0.045 to 0.035 | 0.800 |
| LDL-C (mg/dL) | −0.005 | 0.006 | −0.016 to 0.007 | 0.410 |
SE standard error, FPG fasting plasma glucose, BMI body mass index, CPR index C-peptide immunoreactivity index, LDL-C low-density lipoprotein cholesterol